1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 CIS PROLINE - PRO 9 CIS PROLINE - PRO 81 Constantine, K.L. Colson, K.L. Wittekind, M. Friedrichs, M.S. Zein, N. Tuttle, J. Langley, D.R. Leet, J.E. Schroeder, D.R. Lam, K.S. Farmer II, B.T. Metzler, W.J. Bruccoleri, R.E. Mueller, L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 33 11438 11452 10.1021/bi00204a006 7918358 Sequential 1H, 13C, and 15N NMR assignments and solution conformation of apokedarcidin. 1994 US J.Am.Chem.Soc. JACSAT 0004 0002-7863 115 8432 Chemistry and Structure Elucidation of the Kedarcidin Chromophore 1993 US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 90 2822 Kedarcidin Chromophore: An Enediyne that Cleaves DNA in a Sequence-Specific Manner 1993 US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 90 8009 Selective Proteolytic Activity of the Antitumor Agent Kedarcidin 1993 JA J.Antibiot. JANTAJ 0079 0021-8820 45 1250 Kedarcidin, a New Chromoprotein Antitumor Antibiotic. II. Isolation, Purification and Physico-Chemical Properties 1992 JA J.Antibiot. JANTAJ 0079 0021-8820 44 472 Kedarcidin, a New Chromoprotein Antitumor Antibiotic I. Taxonomy of Producing Organism, Fermentation and Biological Activity 1991 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 10972.936 APOKEDARCIDIN 1 man polymer no no ASAAVSVSPATGLADGATVTVSASGFATSTSATALQCAILADGRGACNVAEFHDFSLSGGEGTTSVVVRRSFTGYVMPDG PEVGAVDCDTAPGGCEIVVGGNTGEYGNAAISFG ASAAVSVSPATGLADGATVTVSASGFATSTSATALQCAILADGRGACNVAEFHDFSLSGGEGTTSVVVRRSFTGYVMPDG PEVGAVDCDTAPGGCEIVVGGNTGEYGNAAISFG A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n L585-6 / ATCC 53650 sample 38989 actinomycete ATCC 53650 pdbx_database_status struct_conf struct_conf_type repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1994-08-31 1 1 2008-03-03 1 2 2011-07-13 1 3 2012-02-22 1 4 2017-11-29 _pdbx_database_status.process_site Y BNL 1994-06-20 REL 15 BRUNGER refinement X-PLOR ALA 1 n 1 ALA 1 A SER 2 n 2 SER 2 A ALA 3 n 3 ALA 3 A ALA 4 n 4 ALA 4 A VAL 5 n 5 VAL 5 A SER 6 n 6 SER 6 A VAL 7 n 7 VAL 7 A SER 8 n 8 SER 8 A PRO 9 n 9 PRO 9 A ALA 10 n 10 ALA 10 A THR 11 n 11 THR 11 A GLY 12 n 12 GLY 12 A LEU 13 n 13 LEU 13 A ALA 14 n 14 ALA 14 A ASP 15 n 15 ASP 15 A GLY 16 n 16 GLY 16 A ALA 17 n 17 ALA 17 A THR 18 n 18 THR 18 A VAL 19 n 19 VAL 19 A THR 20 n 20 THR 20 A VAL 21 n 21 VAL 21 A SER 22 n 22 SER 22 A ALA 23 n 23 ALA 23 A SER 24 n 24 SER 24 A GLY 25 n 25 GLY 25 A PHE 26 n 26 PHE 26 A ALA 27 n 27 ALA 27 A THR 28 n 28 THR 28 A SER 29 n 29 SER 29 A THR 30 n 30 THR 30 A SER 31 n 31 SER 31 A ALA 32 n 32 ALA 32 A THR 33 n 33 THR 33 A ALA 34 n 34 ALA 34 A LEU 35 n 35 LEU 35 A GLN 36 n 36 GLN 36 A CYS 37 n 37 CYS 37 A ALA 38 n 38 ALA 38 A ILE 39 n 39 ILE 39 A LEU 40 n 40 LEU 40 A ALA 41 n 41 ALA 41 A ASP 42 n 42 ASP 42 A GLY 43 n 43 GLY 43 A ARG 44 n 44 ARG 44 A GLY 45 n 45 GLY 45 A ALA 46 n 46 ALA 46 A CYS 47 n 47 CYS 47 A ASN 48 n 48 ASN 48 A VAL 49 n 49 VAL 49 A ALA 50 n 50 ALA 50 A GLU 51 n 51 GLU 51 A PHE 52 n 52 PHE 52 A HIS 53 n 53 HIS 53 A ASP 54 n 54 ASP 54 A PHE 55 n 55 PHE 55 A SER 56 n 56 SER 56 A LEU 57 n 57 LEU 57 A SER 58 n 58 SER 58 A GLY 59 n 59 GLY 59 A GLY 60 n 60 GLY 60 A GLU 61 n 61 GLU 61 A GLY 62 n 62 GLY 62 A THR 63 n 63 THR 63 A THR 64 n 64 THR 64 A SER 65 n 65 SER 65 A VAL 66 n 66 VAL 66 A VAL 67 n 67 VAL 67 A VAL 68 n 68 VAL 68 A ARG 69 n 69 ARG 69 A ARG 70 n 70 ARG 70 A SER 71 n 71 SER 71 A PHE 72 n 72 PHE 72 A THR 73 n 73 THR 73 A GLY 74 n 74 GLY 74 A TYR 75 n 75 TYR 75 A VAL 76 n 76 VAL 76 A MET 77 n 77 MET 77 A PRO 78 n 78 PRO 78 A ASP 79 n 79 ASP 79 A GLY 80 n 80 GLY 80 A PRO 81 n 81 PRO 81 A GLU 82 n 82 GLU 82 A VAL 83 n 83 VAL 83 A GLY 84 n 84 GLY 84 A ALA 85 n 85 ALA 85 A VAL 86 n 86 VAL 86 A ASP 87 n 87 ASP 87 A CYS 88 n 88 CYS 88 A ASP 89 n 89 ASP 89 A THR 90 n 90 THR 90 A ALA 91 n 91 ALA 91 A PRO 92 n 92 PRO 92 A GLY 93 n 93 GLY 93 A GLY 94 n 94 GLY 94 A CYS 95 n 95 CYS 95 A GLU 96 n 96 GLU 96 A ILE 97 n 97 ILE 97 A VAL 98 n 98 VAL 98 A VAL 99 n 99 VAL 99 A GLY 100 n 100 GLY 100 A GLY 101 n 101 GLY 101 A ASN 102 n 102 ASN 102 A THR 103 n 103 THR 103 A GLY 104 n 104 GLY 104 A GLU 105 n 105 GLU 105 A TYR 106 n 106 TYR 106 A GLY 107 n 107 GLY 107 A ASN 108 n 108 ASN 108 A ALA 109 n 109 ALA 109 A ALA 110 n 110 ALA 110 A ILE 111 n 111 ILE 111 A SER 112 n 112 SER 112 A PHE 113 n 113 PHE 113 A GLY 114 n 114 GLY 114 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O ALA 4 A O ALA 4 A N SER 24 A N SER 24 A O ALA 23 A O ALA 23 A N GLY 62 A N GLY 62 A N LEU 57 A N LEU 57 A O THR 30 A O THR 30 A N THR 33 A N THR 33 A O GLY 100 A O GLY 100 A O CYS 95 A O CYS 95 A N ILE 111 A N ILE 111 A N ALA 38 A N ALA 38 A O ALA 46 A O ALA 46 A O PHE 72 A O PHE 72 A N VAL 86 A N VAL 86 1 A ARG 44 0.319 SIDE CHAIN 1 A ARG 69 0.318 SIDE CHAIN 1 A ARG 70 0.311 SIDE CHAIN 2 A ARG 44 0.303 SIDE CHAIN 2 A ARG 69 0.315 SIDE CHAIN 2 A ARG 70 0.306 SIDE CHAIN 3 A ARG 44 0.315 SIDE CHAIN 3 A ARG 69 0.319 SIDE CHAIN 3 A ARG 70 0.319 SIDE CHAIN 4 A ARG 44 0.312 SIDE CHAIN 4 A ARG 69 0.279 SIDE CHAIN 4 A ARG 70 0.320 SIDE CHAIN 5 A ARG 44 0.315 SIDE CHAIN 5 A ARG 69 0.313 SIDE CHAIN 5 A ARG 70 0.319 SIDE CHAIN 6 A ARG 44 0.305 SIDE CHAIN 6 A ARG 69 0.310 SIDE CHAIN 6 A ARG 70 0.318 SIDE CHAIN 7 A ARG 44 0.319 SIDE CHAIN 7 A ARG 69 0.312 SIDE CHAIN 7 A ARG 70 0.310 SIDE CHAIN 8 A ARG 44 0.318 SIDE CHAIN 8 A ARG 69 0.316 SIDE CHAIN 8 A ARG 70 0.319 SIDE CHAIN 9 A ARG 44 0.316 SIDE CHAIN 9 A ARG 69 0.304 SIDE CHAIN 9 A ARG 70 0.317 SIDE CHAIN 10 A ARG 44 0.318 SIDE CHAIN 10 A ARG 69 0.316 SIDE CHAIN 10 A ARG 70 0.320 SIDE CHAIN 11 A ARG 44 0.302 SIDE CHAIN 11 A ARG 69 0.308 SIDE CHAIN 11 A ARG 70 0.318 SIDE CHAIN 12 A ARG 44 0.317 SIDE CHAIN 12 A ARG 69 0.312 SIDE CHAIN 12 A ARG 70 0.320 SIDE CHAIN 13 A ARG 44 0.319 SIDE CHAIN 13 A ARG 69 0.298 SIDE CHAIN 13 A ARG 70 0.316 SIDE CHAIN 14 A ARG 44 0.312 SIDE CHAIN 14 A ARG 69 0.317 SIDE CHAIN 14 A ARG 70 0.314 SIDE CHAIN 15 A ARG 44 0.318 SIDE CHAIN 15 A ARG 69 0.314 SIDE CHAIN 15 A ARG 70 0.317 SIDE CHAIN 14 7.28 1.10 114.20 121.48 A A A CA CB SG CYS CYS CYS 47 47 47 N 1 A A CB CG PHE PHE 52 52 0.104 0.017 1.509 1.613 N 1 A A CG ND1 HIS HIS 53 53 -0.091 0.015 1.369 1.278 N 1 A A CB CG TYR TYR 106 106 0.095 0.015 1.512 1.607 N 3 A A CB CG PHE PHE 52 52 0.104 0.017 1.509 1.613 N 3 A A CB CG TYR TYR 106 106 0.093 0.015 1.512 1.605 N 4 A A CG ND1 HIS HIS 53 53 -0.091 0.015 1.369 1.278 N 4 A A CB CG PHE PHE 72 72 0.105 0.017 1.509 1.614 N 5 A A CG ND1 HIS HIS 53 53 -0.092 0.015 1.369 1.277 N 6 A A CG ND1 HIS HIS 53 53 -0.090 0.015 1.369 1.279 N 7 A A CB CG TYR TYR 75 75 0.091 0.015 1.512 1.603 N 7 A A CB CG TYR TYR 106 106 0.092 0.015 1.512 1.604 N 8 A A CG ND1 HIS HIS 53 53 -0.091 0.015 1.369 1.278 N 8 A A CB CG PHE PHE 55 55 0.111 0.017 1.509 1.620 N 9 A A CG ND1 HIS HIS 53 53 -0.090 0.015 1.369 1.279 N 10 A A CG ND1 HIS HIS 53 53 -0.092 0.015 1.369 1.277 N 11 A A CG ND1 HIS HIS 53 53 -0.093 0.015 1.369 1.276 N 12 A A CB CG PHE PHE 52 52 0.103 0.017 1.509 1.612 N 12 A A CG ND1 HIS HIS 53 53 -0.091 0.015 1.369 1.278 N 13 A A CG ND1 HIS HIS 53 53 -0.092 0.015 1.369 1.277 N 13 A A CB CG TYR TYR 106 106 0.096 0.015 1.512 1.608 N 14 A A CB CG TYR TYR 75 75 0.093 0.015 1.512 1.605 N 15 A A CG ND1 HIS HIS 53 53 -0.092 0.015 1.369 1.277 N 1 A SER 8 -160.42 113.01 1 A ALA 10 -140.22 -8.65 1 A ALA 27 -168.95 -59.15 1 A HIS 53 -133.82 -63.93 1 A ASP 54 53.41 98.50 1 A MET 77 48.20 169.49 2 A ALA 3 59.40 -173.23 2 A SER 8 -160.88 111.85 2 A PHE 26 58.90 146.62 2 A ALA 27 -163.88 -37.74 2 A THR 28 -136.84 -30.09 2 A HIS 53 -146.17 -60.06 2 A ASP 54 45.44 93.70 2 A ASP 79 -160.12 -47.33 2 A VAL 83 -79.92 -92.57 2 A THR 103 -69.90 -70.66 2 A ALA 109 -161.90 98.36 3 A ALA 3 62.02 -172.01 3 A ALA 27 -165.38 -38.24 3 A HIS 53 -143.79 -66.63 3 A ASP 54 52.22 127.81 3 A PHE 55 -172.84 145.43 3 A ASP 79 -160.05 -60.32 3 A GLU 105 62.15 -94.19 3 A ALA 109 -161.47 94.71 4 A SER 2 -144.63 11.38 4 A ALA 10 -141.54 -8.18 4 A ALA 27 -66.85 -70.55 4 A HIS 53 -146.24 -61.52 4 A ASP 54 56.55 99.53 4 A ASP 79 -160.27 -43.04 4 A THR 103 -70.00 -70.88 4 A ALA 109 -162.30 99.36 5 A ALA 27 -158.82 -30.52 5 A THR 28 -143.59 -40.38 5 A HIS 53 -148.25 -44.65 5 A ASP 54 63.49 130.88 5 A ASP 79 -160.13 -47.50 5 A ALA 109 -164.12 102.19 6 A ALA 27 -160.81 -18.64 6 A HIS 53 -145.42 -52.99 6 A ASP 54 51.37 97.24 6 A ASP 79 -160.17 -45.23 6 A ALA 109 -164.13 109.78 6 A SER 112 -161.19 119.65 7 A SER 2 -167.47 -40.14 7 A ALA 10 -141.15 -5.31 7 A ALA 27 -161.11 -21.99 7 A HIS 53 -145.85 -61.35 7 A ASP 54 59.43 112.30 7 A ASP 79 -158.53 -39.98 8 A SER 2 -167.56 91.62 8 A SER 8 -161.30 112.92 8 A ALA 27 -160.73 -20.73 8 A ALA 34 -161.10 117.98 8 A HIS 53 -144.87 -54.73 8 A ASP 54 67.71 128.58 8 A ASP 79 -160.15 -46.63 8 A ALA 109 -161.45 100.35 9 A SER 2 -163.98 -40.92 9 A SER 8 -161.84 112.87 9 A ALA 27 -160.76 -18.71 9 A MET 77 56.58 169.01 9 A ASP 89 -164.42 -36.78 9 A ASN 108 66.65 116.06 9 A ALA 109 -161.90 106.26 10 A ALA 10 -144.26 -6.58 10 A ALA 27 -163.35 -18.92 10 A SER 31 -170.06 133.57 10 A HIS 53 -137.94 -61.18 10 A ASP 54 52.86 97.56 10 A MET 77 48.80 172.08 10 A GLU 105 67.97 168.20 10 A ALA 109 -161.24 93.85 11 A SER 2 -167.52 92.13 11 A ALA 27 -158.20 -16.99 11 A HIS 53 -152.42 -64.29 11 A PHE 55 -136.92 -157.74 11 A ASP 79 -160.13 -53.33 11 A THR 103 -70.61 -73.80 11 A ASN 108 63.85 121.14 11 A ALA 109 -164.39 96.86 11 A SER 112 -163.65 115.01 12 A SER 2 -166.80 90.89 12 A ALA 3 57.79 80.04 12 A ALA 27 -162.19 -15.55 12 A HIS 53 -138.39 -67.37 12 A ASP 54 52.83 101.22 12 A ASP 79 -79.93 -72.53 12 A VAL 83 -79.91 -85.55 12 A GLU 105 62.70 -85.36 12 A ALA 109 -160.67 102.22 13 A ALA 10 -141.14 -1.46 13 A ALA 27 -167.60 -37.22 13 A ALA 34 -160.66 112.60 13 A HIS 53 -145.54 -43.01 13 A ASP 79 -160.11 -56.30 13 A ASP 89 -161.89 -32.56 14 A SER 2 -163.15 89.95 14 A ALA 27 -161.50 -20.24 14 A HIS 53 -152.15 -50.14 14 A ASP 79 -79.90 -72.14 14 A VAL 83 -79.83 -78.66 14 A ASP 89 -166.40 -37.33 14 A ALA 109 -163.17 95.57 15 A ALA 27 -160.10 -19.51 15 A HIS 53 -139.18 -52.42 15 A ASP 54 45.58 116.10 15 A PHE 55 -171.22 144.04 15 A MET 77 48.07 163.23 15 A VAL 83 -79.82 -87.34 15 A ASP 89 -164.15 -32.73 15 A GLU 105 63.89 173.09 15 A ASN 108 62.58 105.82 model building X-PLOR refinement X-PLOR phasing X-PLOR APOKEDARCIDIN (APO FORM OF KEDARCIDIN) (NMR, 15 STRUCTURES) SEQUENTIAL 1H,13C AND 15N NMR ASSIGNMENTS AND SOLUTION CONFORMATION OF APOKEDARCIDIN 1 Y N A VAL 49 A VAL 49 HELX_P TYPE III (HELIX-LIKE) TURN A PHE 52 A PHE 52 1 I 4 A CYS 88 A CYS 88 HELX_P TYPE III (HELIX-LIKE) TURN A ALA 91 A ALA 91 1 II 4 disulf 2.022 A CYS 37 A SG CYS 37 1_555 A CYS 47 A SG CYS 47 1_555 disulf 2.015 A CYS 88 A SG CYS 88 1_555 A CYS 95 A SG CYS 95 1_555 ANTIBIOTIC CHROMOPROTEIN ANTIBIOTIC CHROMOPROTEIN A SER 8 A SER 8 1 A PRO 9 A PRO 9 -3.28 A GLY 80 A GLY 80 1 A PRO 81 A PRO 81 -1.52 A SER 8 A SER 8 2 A PRO 9 A PRO 9 -3.96 A GLY 80 A GLY 80 2 A PRO 81 A PRO 81 0.09 A SER 8 A SER 8 3 A PRO 9 A PRO 9 -3.70 A GLY 80 A GLY 80 3 A PRO 81 A PRO 81 -1.07 A SER 8 A SER 8 4 A PRO 9 A PRO 9 -3.02 A GLY 80 A GLY 80 4 A PRO 81 A PRO 81 0.13 A SER 8 A SER 8 5 A PRO 9 A PRO 9 -2.65 A GLY 80 A GLY 80 5 A PRO 81 A PRO 81 0.05 A SER 8 A SER 8 6 A PRO 9 A PRO 9 -4.38 A GLY 80 A GLY 80 6 A PRO 81 A PRO 81 -0.10 A SER 8 A SER 8 7 A PRO 9 A PRO 9 -3.96 A GLY 80 A GLY 80 7 A PRO 81 A PRO 81 0.79 A SER 8 A SER 8 8 A PRO 9 A PRO 9 -4.59 A GLY 80 A GLY 80 8 A PRO 81 A PRO 81 -0.13 A SER 8 A SER 8 9 A PRO 9 A PRO 9 -4.12 A GLY 80 A GLY 80 9 A PRO 81 A PRO 81 -0.67 A SER 8 A SER 8 10 A PRO 9 A PRO 9 -3.34 A GLY 80 A GLY 80 10 A PRO 81 A PRO 81 -1.25 A SER 8 A SER 8 11 A PRO 9 A PRO 9 -4.05 A GLY 80 A GLY 80 11 A PRO 81 A PRO 81 -0.54 A SER 8 A SER 8 12 A PRO 9 A PRO 9 -3.81 A GLY 80 A GLY 80 12 A PRO 81 A PRO 81 -6.86 A SER 8 A SER 8 13 A PRO 9 A PRO 9 -2.99 A GLY 80 A GLY 80 13 A PRO 81 A PRO 81 -0.87 A SER 8 A SER 8 14 A PRO 9 A PRO 9 -2.80 A GLY 80 A GLY 80 14 A PRO 81 A PRO 81 -6.13 A SER 8 A SER 8 15 A PRO 9 A PRO 9 -4.36 A GLY 80 A GLY 80 15 A PRO 81 A PRO 81 -1.03 KEDA_ACTSL UNP 1 1 P41249 ASAAVSVSPATGLADGATVTVSASGFATSTSATALQCAILADGRGACNVAEFHDFSLSGGEGTTSVVVRRSFTGYVMPDG PEVGAVDCDTAPGGCEIVVGGNTGEYGNAAISFG 1 114 1AKP 1 114 P41249 A 1 1 114 3 4 2 2 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A ALA 4 A ALA 4 A SER 8 A SER 8 A ALA 17 A ALA 17 A GLY 25 A GLY 25 A GLU 61 A GLU 61 A VAL 68 A VAL 68 A HIS 53 A HIS 53 A LEU 57 A LEU 57 A THR 30 A THR 30 A LEU 40 A LEU 40 A GLY 94 A GLY 94 A GLY 101 A GLY 101 A TYR 106 A TYR 106 A GLY 114 A GLY 114 A THR 30 A THR 30 A LEU 40 A LEU 40 A ARG 44 A ARG 44 A ASN 48 A ASN 48 A SER 71 A SER 71 A VAL 76 A VAL 76 A VAL 83 A VAL 83 A ASP 87 A ASP 87 Unknown 15 A THR 33 A THR 33 15 1_555 A LEU 35 A LEU 35 15 1_555 A CYS 37 A CYS 37 15 1_555 A ILE 39 A ILE 39 15 1_555 A ARG 44 A ARG 44 15 1_555 A CYS 47 A CYS 47 15 1_555 A VAL 49 A VAL 49 15 1_555 A PHE 52 A PHE 52 15 1_555 A ASP 54 A ASP 54 15 1_555 A TYR 75 A TYR 75 15 1_555 A MET 77 A MET 77 15 1_555 A GLU 96 A GLU 96 15 1_555 A VAL 98 A VAL 98 15 1_555 A TYR 106 A TYR 106 15 1_555 A ASN 108 A ASN 108 15 1_555 1 P 1